MOKAN Wealth Management Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2053727 OVERLAND PARK, KS

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,313,809

+$550,201 QoQ

Shares Held

10,399

+89.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#967

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 5% None 95%

Healthcare · as of Jun 30, 2026

MOKAN Wealth Management Inc. holds $20,473,093 across 6 Drug Manufacturers - General names. GILD ranks #5 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	48,990	$6,295,215
2	ABBV	AbbVie Inc.	23,835	$5,997,839
3	LLY	ELI LILLY & Co	4,208	$5,047,201
4	JNJ	Johnson & Johnson	5,872	$1,491,311
5	GILD	Gilead Sciences, Inc. This page	10,399	$1,313,809
6	AMGN	Amgen Inc	905	$327,718

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,313,809	10,399	+89.8%	Shares	Sole	2026-07-28
2026-03-31	$763,608	5,479	-6.1%	Shares	Sole	2026-05-01
2025-12-31	$716,310	5,836	-20.0%	Shares	Sole	2026-01-26
2025-09-30	$809,412	7,292	-62.3%	Shares	Sole	2025-10-30
2025-06-30	$2,145,556	19,352	+18.9%	Shares	Sole	2025-07-25
2025-03-31	$1,824,174	16,280	-13.3%	Shares	Sole	2025-04-23
2024-12-31	$1,734,616	18,779	—	Shares	Sole	2025-01-30
No filing history on record for this holder in this stock.